Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.18.7913

Over-Expression of Beclin-1 Facilitates Acquired Resistance to Histone Deacetylase Inhibitor-Induced Apoptosis  

Wang, Shi-Miao (School of Life Science and Biotechnology, Dalian University of Technology)
Li, Xiao-Hui (School of Life Science and Biotechnology, Dalian University of Technology)
Xiu, Zhi-Long (School of Life Science and Biotechnology, Dalian University of Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.18, 2014 , pp. 7913-7917 More about this Journal
Abstract
Apoptotic cell death plays a predominant role in histone deacetylase (HDAC) inhibitor-induced cytotoxicity. Nuclear morphological changes and activation of apoptotic executors are involved in CTS203-induced cell death. However, emerging issues of HDAC inhibitor-resistance have been observed in patients. Herein, MCF-7 cells were continuously exposed to CTS203 until the derived cells could proliferate normally in its presence. The newly obtained CTS203-resistant cells were nominated as MCF-7/203R. Compared to MCF-7 original cells, the MCF-7/203R cells were less sensitive to CTS203-induced apoptosis, with a minimal 6-fold higher $IC_{50}$ value. In contrast, the expression of Beclin-1 was dramatically up-regulated, positively correlated to the acquisition of CTS203-resistance. Our results revealed the participation of autophagy in acquired HDAC inhibitor-resistance and further identified Beclin-1 as a promising target for anti-drug resistance.
Keywords
HDAC inhibitor; drug resistance; Beclin-1; autophagy; apoptosis;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Chen YT, Feng B, Chen LB (2012). Update of research on drug resistance in small cell lung cancer chemotherapy. Asian Pac J Cancer Prev, 13, 3577-81.   과학기술학회마을   DOI   ScienceOn
2 Abedin MJ, Wang D, McDonnell MA, et al (2007). Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ, 14, 500-10.   DOI   ScienceOn
3 Apel A, Herr I, Schwarz H, et al (2008). Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. Cancer Res, 68, 1485-94.   DOI   ScienceOn
4 Cai M, Hu Z, Liu J, et al (2014). Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int J Mol Sci, 15, 5292-303.   DOI   ScienceOn
5 Carew JS, Nawrocki ST, Kahue CN, et al (2007). Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood, 110, 313-22.   DOI   ScienceOn
6 Chen SY, Hu SS, Dong Q, et al (2013). Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo. Asian Pac J Cancer Prev, 14, 6135-40.   과학기술학회마을   DOI   ScienceOn
7 Debatin KM (2004). Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immun, 53, 153-9.   DOI   ScienceOn
8 Eisenberg-Lerner A, Bialik S, Simon HU, et al (2009). Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ, 16, 966-75.   DOI   ScienceOn
9 Fantin VR, Richon VM (2007). Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications. Clin Cancer Res, 13, 7237-42.   DOI   ScienceOn
10 Gu W, Fang FF, Li B, et al (2012). Characterization and resistance mechanisms of A 5-fluorouracil-resistant hepatocellular carcinoma cell line. Asian Pac J Cancer Prev, 13, 4807-14.   DOI   ScienceOn
11 Hou W, Han J, Lu C, et al (2010). Autophagic degradation of active caspase-8: a crosstalk mechanism between autophagy and apoptosis. Autophagy, 6, 891-900.   DOI   ScienceOn
12 Jänicke RU (2009). MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Tr, 117, 219-21.   DOI
13 Li Z, Chen B, Wu Y, et al (2010). Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer, 10, 98.   DOI   ScienceOn
14 Juengel E, Makarevic J, Tsaur I, et al (2013). Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo. PLoS One, 8, 53100.   DOI
15 Wang NN, Zhao LJ, Wu LN, et al (2013). Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line. Asian Pac J Cancer Prev, 14, 4983-8.   과학기술학회마을   DOI   ScienceOn
16 Kang R, Zeh HJ, Lotze MT, et al (2011). The beclin 1 network regulates autophagy and apoptosis. Cell Death Differ, 18, 571-80.   DOI   ScienceOn
17 Kim HJ, Bae SC (2011). Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anticancer drugs. Am J Transl Res, 3, 166-79.
18 Sun Y, Liu J, Sui Y, et al (2011). Beclin-1 overexpression inhibits proliferation, invasion and migration of CaSki cervical cancer cells. Asian Pac J Cancer Prev, 12, 1269-73.
19 Wang S, Li X, Wei Y, et al (2014). Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. ChemMedChem, 9, 627-37.   DOI   ScienceOn
20 Xu CY, Jiang ZN, Zhou Y, et al (2013). Estrogen receptor $\alpha$ roles in breast cancer chemoresistance. Asian Pac J Cancer Prev, 14, 4049-52.   과학기술학회마을   DOI   ScienceOn
21 Yang ZJ, Chee CE, Huang S, et al (2011). The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther, 10, 1533-41.   DOI
22 Yokoyama T, Kondo Y, Bogler O, et al (2009). The Role of Autophagy and Apoptosis in the Drug Resistance of Cancer. Springer, New York.